Experimentation of Sensorized Pseudoelastic Orthoses Produced by Additive Manufacturing

February 6, 2023 updated by: IRCCS Eugenio Medea

The proposed clinical investigation plan is a pivotal controlled study with two parallel groups, has a total duration of 12 months and involves the recruitment of 34 pediatric patients suffering from acquired brain injury.

The primary objective of the clinical study is to evaluate the improvement of joint stiffness through the use of sensorized pseudoelastic orthoses for the rehabilitation of pediatric patients with acquired brain injury.

The effectiveness of the treatment in terms of joint stiffness (primary outcome) will be assessed and the effect of the treatment will be quantified with clinical evaluation scales and instrumental measurements by means of an optoelectronic system and isokinetic machine. The tolerability and acceptability of the device will also be checked.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • LC
      • Bosisio Parini, LC, Italy, 23842

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 20 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Quadriplegia or acquired hemiplegia.
  2. Age 6-20 years.
  3. Dystonic, dyskinetic, spastic.
  4. Chronic phase patients (> 1 year post event).
  5. Spastic syndrome with Ashworth Score (AS) for the limb of interest> 1.
  6. Collaborative.

Exclusion Criteria:

  1. Fixed limitations of the joint.
  2. Joint pain.
  3. Skin allergies.
  4. Behavioral and psychiatric disorders (eg, emotional problems, anxiety, panic attacks).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Treatment
Upper limb rehabilitation with pseudoelastic orthosis
The subject will be given specific physiotherapy including activities oriented to multimodal exploration and refinement of gross and fine motor skills, customized according to the functional status of the individual patient.
NO_INTERVENTION: Control
Upper limb rehabilitation without pseudoelastic orthosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Joint Stiffness of affected upper limb joint
Time Frame: After 4 weeks of treatment
Quantitative measure performed by means of an isokinetic machine (Unit of measure: Nm/°). Changes in joint stiffness following the use of new customized devices during a rehabilitation treatment period. Lower stiffness is better.
After 4 weeks of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale
Time Frame: After 4 weeks of treatment
Clinical scale for spasticity (5 levels), higher is worse.
After 4 weeks of treatment
Melbourne Upper Limb Assessment 2
Time Frame: After 4 weeks of treatment
Clinical scale for evaluating quality of upper limb movement (16 items, each assessed from 0 to 4 points). Result reported in %. Higher is better.
After 4 weeks of treatment
Quality of Upper Extremity Skills Test
Time Frame: After 4 weeks of treatment
Clinical scale evaluating the quality of upper extremity function (33 items, 4 domains). Minimum score 0, maximum score 100. Higher is better.
After 4 weeks of treatment
Active range of motion
Time Frame: After 4 weeks of treatment
Measured with goniometer in degrees.
After 4 weeks of treatment
Passive range of motion
Time Frame: After 4 weeks of treatment
Measured with goniometer in degrees.
After 4 weeks of treatment
Range of motion of target joint during a pointing-forward task
Time Frame: After 4 weeks of treatment
Measured in degrees. A kinematic analysis will be performed during a pointing-forward task using an optoelectronic system.
After 4 weeks of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2020

Primary Completion (ANTICIPATED)

May 31, 2023

Study Completion (ANTICIPATED)

May 31, 2023

Study Registration Dates

First Submitted

February 27, 2020

First Submitted That Met QC Criteria

March 30, 2020

First Posted (ACTUAL)

March 31, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe